Historical record - last NADAC effective date: 7/17/2024
Product Information
TEMOZOLOMIDE 100 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $8.9168 per EA under NDC 47335089280. Its NADAC has been published 202 times since Apr 9, 2014.
FDA first approved this application on Feb 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335089280
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201742FDA Approved
2/12/2014
TE Code
AB
On Market Since
2/13/2014
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 100 MG CAPSULE has been published 202 times since Apr 9, 2014, and over the history we have for it it has declined 94.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9168 per EA |
|---|---|
| All-time high | $158.3420 (Apr 16, 2014) |
| All-time low | $8.9168 (Jul 17, 2024) |
| Median price | $119.6096 |
| Average price | $104.3729 |
| Largest weekly change | -89.0% (May 22, 2024) |
| Weeks tracked | 202 |
| Tracking since | Apr 9, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-89.0%
5Y
-89.0%
All
-94.4%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 100 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $8.9168 per EA (NDC 47335089280), effective Aug 14, 2024.
How has the price of TEMOZOLOMIDE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 100 MG CAPSULE has declined 94.4%. It has been tracked across 202 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 100 MG CAPSULE?
Since Apr 9, 2014, the NADAC for TEMOZOLOMIDE 100 MG CAPSULE has ranged from a low of $8.9168 (Jul 17, 2024) to a high of $158.3420 (Apr 16, 2014), with a median of $119.6096 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 100 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TEMOZOLOMIDE 100 MG CAPSULE, is $4.7610 per EA — about 47% below TEMOZOLOMIDE 100 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 100 MG CAPSULE?
TEMOZOLOMIDE 100 MG CAPSULE (NDC 47335089280) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.